#  @AstraZeneca AstraZeneca AstraZeneca posts on X about science, we are, $azn, in the the most. They currently have [-------] followers and [---] posts still getting attention that total [--] engagements in the last [--] hours. ### Engagements: [--] [#](/creator/twitter::62465691/interactions)  - [--] Week [-----] -22% - [--] Month [------] +621% - [--] Months [-------] +360% - [--] Year [-------] -39% ### Mentions: [--] [#](/creator/twitter::62465691/posts_active)  - [--] Week [--] -43% - [--] Month [-----] +20,167% - [--] Months [-----] +9,070% - [--] Year [-----] +1,506% ### Followers: [-------] [#](/creator/twitter::62465691/followers)  - [--] Week [-------] -0.01% - [--] Month [-------] -0.09% - [--] Months [-------] -0.71% - [--] Year [-------] -1.60% ### CreatorRank: [---------] [#](/creator/twitter::62465691/influencer_rank)  ### Social Influence **Social category influence** [stocks](/list/stocks) 99.04% [currencies](/list/currencies) 6.73% [countries](/list/countries) 2.88% [travel destinations](/list/travel-destinations) 1.92% [finance](/list/finance) 0.96% [exchanges](/list/exchanges) 0.96% **Social topic influence** [science](/topic/science) 18.27%, [we are](/topic/we-are) 10.58%, [$azn](/topic/$azn) 7.69%, [in the](/topic/in-the) 6.73%, [future](/topic/future) 3.85%, [the world](/topic/the-world) 3.85%, [to the](/topic/to-the) 3.85%, [lives of](/topic/lives-of) 2.88%, [up to](/topic/up-to) 2.88%, [countries](/topic/countries) 1.92% **Top accounts mentioned or mentioned by** [@muhayadina38422](/creator/undefined) [@inibica_iis](/creator/undefined) [@waynetlc](/creator/undefined) [@insoligopoly](/creator/undefined) [@apy_fiz](/creator/undefined) [@_anuragaashish_](/creator/undefined) [@menepangalos](/creator/undefined) [@wethenorth47](/creator/undefined) [@vgrandrounds](/creator/undefined) [@diariomedico](/creator/undefined) [@yicaichina](/creator/undefined) [@cfarmaceutico](/creator/undefined) [@asmadual](/creator/undefined) [@drlovetruth](/creator/undefined) [@baiaforequality](/creator/undefined) [@caleblareau](/creator/undefined) [@adpdnet](/creator/undefined) [@careawards](/creator/undefined) [@emulatebio](/creator/undefined) [@pitchatpalace](/creator/undefined) **Top assets mentioned** [AstraZeneca PLC (AZN)](/topic/$azn) [Novartis AG (NVS)](/topic/novartis) [Gilead Sciences, Inc. (GILD)](/topic/gilead-sciences) [AbbVie Inc (ABBV)](/topic/$abbv) ### Top Social Posts Top posts by engagements in the last [--] hours "While the definition of a rare disease varies across countries the number of people affected remains significant. Improving equitable access to healthcare for those living with rare diseases is essential. #RareDisease" [X Link](https://x.com/anyuser/status/2003100234860077086) 2025-12-22T13:48Z 293.3K followers, [----] engagements "#News Exciting newswe are now trading our ordinary shares on the New York Stock Exchange (NYSE) for the first time aligning trading across the NYSE London Stock Exchange (LSE) and Nasdaq Stockholm (STO) under a harmonised global listing structure. #AZN" [X Link](https://x.com/AstraZeneca/status/2018218407011733886) 2026-02-02T07:02Z 293.3K followers, [----] engagements "Newborn screenings and genetic testing play a critical role in accelerating diagnosis and reducing healthcare costs yet access remains limited. Expanding availability of these diagnostic tools can support earlier diagnosis of rare diseases. #RareDisease" [X Link](https://x.com/AstraZeneca/status/2020845136658206872) 2026-02-09T13:00Z 293.3K followers, [----] engagements "#News for #Investors and #Media📈 [----] was another year of strong growth with excellent pipeline delivery across all therapy areas and major regions. Watch our CEO Pascal Soriot share our FY [----] results and learn more: #AZN #FinancialResults https://learn.az/6013h3PrH https://learn.az/6013h3PrH" [X Link](https://x.com/AstraZeneca/status/2021120188062617749) 2026-02-10T07:12Z 293.3K followers, [----] engagements "We're working to reduce the burden of CVD by taking the distinctive approach of jointly addressing cardio-renal-metabolic risks #CVD #ACC18" [X Link](https://x.com/AstraZeneca/status/973274939947012096) 2018-03-12T19:10Z 293.4K followers, [--] engagements "#ACC18 is over but the conversation for #CVMD patients is not. Lets continue to discuss how and where these diseases intersect to improve patient outcomes" [X Link](https://x.com/AstraZeneca/status/973563342206918656) 2018-03-13T14:16Z 293.4K followers, [--] engagements "Today we're mentoring entrepreneurs at the #pitchatpalace [---] bootcamp - a great initiative by @TheDukeOfYork to support start-ups develop their business ideas https://x.com/pitchatpalace/status/973473599695867905 [--] Entrepreneurs will Pitch their innovative business idea to an audience of 150+ today and receive business mentoring from their Elevators. https://x.com/pitchatpalace/status/973473599695867905 [--] Entrepreneurs will Pitch their innovative business idea to an audience of 150+ today and receive business mentoring from their Elevators" [X Link](https://x.com/AstraZeneca/status/973571454527733760) 2018-03-13T14:48Z 293.4K followers, [--] engagements "Today IMED Biotech Unit's @MenePangalos is presenting at the @PistoiaAlliance Conference on the importance of open collaboration in science #Pistoia2018 #collaboration" [X Link](https://x.com/AstraZeneca/status/973886740531265536) 2018-03-14T11:41Z 293.4K followers, [--] engagements "We are excited to participate in the valuable scientific discussions on advancing #Alzheimers research at @adpdnet #AATADPD" [X Link](https://x.com/AstraZeneca/status/974181162821173248) 2018-03-15T07:11Z 293.4K followers, [--] engagements "47 million people live with #Alzheimers disease and dementia globally. Increasing patient involvement in research can help improve the future of treatment. #AATADPD http://bit.ly/2FCzj1S http://bit.ly/2FCzj1S" [X Link](https://x.com/AstraZeneca/status/974557145973714944) 2018-03-16T08:05Z 293.4K followers, [--] engagements "Thank you @ADPDNet for hosting such valuable discussions on the future of #Alzheimers research. #AATADPD" [X Link](https://x.com/AstraZeneca/status/975316149767254016) 2018-03-18T10:21Z 293.4K followers, [--] engagements "Our CEO Pascal Soriot gave the second annual Kate Pretty lecture at @HomertonCollege part of University of Cambridge. He covered the need for life science clusters to drive innovation and discovery through collaboration and convergence" [X Link](https://x.com/AstraZeneca/status/976099137555808256) 2018-03-20T14:12Z 293.4K followers, [--] engagements "We are excited to be in Dusseldorf for #Lupus2018 to join the conversation on advancing #lupus research" [X Link](https://x.com/AstraZeneca/status/976135554344542208) 2018-03-20T16:37Z 293.4K followers, [--] engagements "For those following #Lupus2018 take a moment for a refresher on five important facts about #lupus" [X Link](https://x.com/AstraZeneca/status/976386697523994624) 2018-03-21T09:15Z 293.4K followers, [--] engagements "#Lupus manifests itself differently in each patient making it difficult to diagnose. These are some but not all of the common symptoms of this autoimmune condition #Lupus2018" [X Link](https://x.com/AstraZeneca/status/976733291532337153) 2018-03-22T08:12Z 293.4K followers, [--] engagements "By using the treat-to-target approach clinicians could improve treatment outcomes for patients. It involves identifying specific goals in the management of chronic diseases such as #lupus. #Lupus2018" [X Link](https://x.com/AstraZeneca/status/976798919018496000) 2018-03-22T12:33Z 293.4K followers, [--] engagements "Our renamed Cardiovascular Renal & Metabolism therapy area recognises the importance of #Renal conditions in our distinctive approach to addressing patients cardio-renal-metabolic risks. http://bit.ly/2G3e5qk http://bit.ly/2G3e5qk" [X Link](https://x.com/AstraZeneca/status/977148739075825665) 2018-03-23T11:43Z 293.4K followers, [--] engagements "With only one new treatment approved in the last [--] years #lupus is an area of significant unmet need for patients. #Lupus2018" [X Link](https://x.com/AstraZeneca/status/977161049156628480) 2018-03-23T12:32Z 293.4K followers, [--] engagements "Rheumatologist Eric Morand believes that combining treat-to-target with new therapies could revolutionise the treatment of #lupus. #Lupus2018 http://bit.ly/2FQrMN7 http://bit.ly/2FQrMN7" [X Link](https://x.com/AstraZeneca/status/977460531396096001) 2018-03-24T08:22Z 293.4K followers, [--] engagements "As the @SLEuroSociety #Lupus2018 meeting ends AstraZeneca continues to be committed to improving the treatment of #lupus by pushing the boundaries of research and exploring the drivers of the disease" [X Link](https://x.com/AstraZeneca/status/977498277036769281) 2018-03-24T10:52Z 293.4K followers, [--] engagements "It is important to learn more about the drivers of #lupus. Thats why were conducting a prospective observational study called SPOCS. #lupus2018" [X Link](https://x.com/AstraZeneca/status/977515884703969282) 2018-03-24T12:02Z 293.4K followers, [--] engagements "Thank you #Lupus2018 for important conversations on scientific innovation and treatment approaches in #lupus. Our commitment to patients continues" [X Link](https://x.com/AstraZeneca/status/977578796533522433) 2018-03-24T16:12Z 293.4K followers, [--] engagements "Early diagnosis is an important area of improvement for #OvarianCancer patients. Outcomes are significantly improved if patients are diagnosed at early stages. #SGOMtg #gyncsm" [X Link](https://x.com/AstraZeneca/status/977606984714219520) 2018-03-24T18:04Z 293.4K followers, [--] engagements "Our IMED Biotech Unit is diversifying their chemical toolbox to explore novel biology and tap into 55% of the biologically-linked genome waiting to be explored. Find out how were working to discover more innovative therapies for patients than ever before: http://bit.ly/2DT2AQp http://bit.ly/2DT2AQp" [X Link](https://x.com/AstraZeneca/status/978920642518032384) 2018-03-28T09:04Z 293.4K followers, [--] engagements "WSJ.com - Hurdles Multiply for Latest Drugs http://t.co/1uM6gUf http://on.wsj.com/otQNLS http://on.wsj.com/otQNLS" [X Link](https://x.com/AstraZeneca/status/97994868919504896) 2011-08-01T11:39Z 293.4K followers, [--] engagements "We are proud to be this years no.1 on @ideapharma Pharmaceutical Innovation Index. It is an acknowledgement of the work of our dedicated people and our partners across the world their real passion for science and patient focus. $AZN https://x.com/ideapharma/status/979034387407781891 The [----] Pharmaceutical Innovation Index [--]. @AstraZeneca [--]. @GileadSciences [--]. @JNJNews [--]. @Novartis [--]. @abbvie [--]. @bmsnews [--]. @Merck [--]. @Roche [--]. @pfizer [--]. @biogen 11-32 here: https://t.co/V6Jli1Ayzb https://t.co/N3duZKE9JZ https://x.com/ideapharma/status/979034387407781891 The [----] Pharmaceutical Innovation" [X Link](https://x.com/AstraZeneca/status/980858199791333376) 2018-04-02T17:23Z 293.4K followers, [--] engagements "We are committed to putting patients first. We aspire to enhance and extend the lives of people with #BloodCancer by following the science to explore new treatment options" [X Link](https://x.com/AstraZeneca/status/981083155015729153) 2018-04-03T08:17Z 293.4K followers, [--] engagements "Up to 40% of patients diagnosed with hairy cell #leukaemia will ultimately relapse. New therapies are needed for patients with relapsed or refractory disease #BloodCancer" [X Link](https://x.com/AstraZeneca/status/981159140180443138) 2018-04-03T13:19Z 293.4K followers, [--] engagements "@ryannoyed rude" [X Link](https://x.com/AstraZeneca/status/981887455002537984) 2018-04-05T13:33Z 293.4K followers, [--] engagements "Positive agreement received for approval of AXANUM (low-dose ASA/esomeprazole) in Europe http://ow.ly/5SSm6" [X Link](https://x.com/AstraZeneca/status/98322220069298176) 2011-08-02T09:20Z 293.4K followers, [--] engagements "We applaud the steering group supported by @VaccinesEurope for their efforts around raising influenza awareness and EU vaccination rates to reduce the burden of this disease in Europe. Read our blog to find out how you can support these efforts: http://bit.ly/2qbTIAo http://bit.ly/2qbTIAo" [X Link](https://x.com/AstraZeneca/status/983313089461346304) 2018-04-09T11:58Z 293.4K followers, [--] engagements "Were working hard to understand the reasons behind the increasing burden of #CVD and how to best tackle it as the worlds leading cause of mortality" [X Link](https://x.com/AstraZeneca/status/983329451558621184) 2018-04-09T13:03Z 293.4K followers, [--] engagements "The impact of #CVD can be immediate and long-lasting. People who develop the disease may be at increased risk of related conditions such as kidney disease and diabetes. Were committed to solving this problem by redefining the way these diseases are understood and treated #CVRM" [X Link](https://x.com/AstraZeneca/status/983371227384299520) 2018-04-09T15:49Z 293.4K followers, [--] engagements "Our approach to studying the real-world impact of #cardiovascular diseases is designed to bring about better outcomes for patients" [X Link](https://x.com/AstraZeneca/status/983386612645093376) 2018-04-09T16:50Z 293.4K followers, [--] engagements "Identifying #biomarkers such as #EGFR or ALK can help determine how best to target #lungcancer. Were excited to discuss progress in precision medicine at #ELCC18" [X Link](https://x.com/AstraZeneca/status/984420387789258752) 2018-04-12T13:18Z 293.4K followers, [--] engagements "@kateandclaudius @kateandclaudius Please find our report here: http://bit.ly/2v8ohNn http://bit.ly/2v8ohNn" [X Link](https://x.com/AstraZeneca/status/984556338100523008) 2018-04-12T22:18Z 293.4K followers, [--] engagements "Identifying novel risk factors for cardiovascular disease is one way our scientists in the IMED Biotech Unit are defining the 'Right Target in drug discovery. Read more about our 5R framework research approach: http://bit.ly/2DtJu7b http://bit.ly/2DtJu7b" [X Link](https://x.com/AstraZeneca/status/984714388115406850) 2018-04-13T08:46Z 293.4K followers, [--] engagements "Thank you Geneva and @myESMO for a wonderful #ELCC18. Weve had a great time sharing our #science and learning from our colleagues from around the world. Now onwards to Chicago for #AACR18" [X Link](https://x.com/AstraZeneca/status/985121500226179072) 2018-04-14T11:44Z 293.4K followers, [--] engagements "Metastases in the central nervous system are difficult to treat due to the blood-brain barrier. Penetrating the barrier remains a significant challenge for researchers looking for ways to improve #lungcancer treatments #AACR18" [X Link](https://x.com/AstraZeneca/status/985534981937053703) 2018-04-15T15:07Z 293.4K followers, [--] engagements "We strive to put patients first and are working every day to improve the lives of people living with #lungcancer through research #LCSM" [X Link](https://x.com/AstraZeneca/status/986952819763638272) 2018-04-19T13:01Z 293.4K followers, [--] engagements "Testing for biomarkers at first diagnosis of #lungcancer is important to help doctors and patients better understand their disease #LCSM" [X Link](https://x.com/AstraZeneca/status/986998368164446209) 2018-04-19T16:02Z 293.4K followers, [--] engagements "Were committed to driving forward research in #lungcancer to fulfil our ambition of improving outcomes for all patients across different stages and types of disease #LCSM" [X Link](https://x.com/AstraZeneca/status/987043933430493184) 2018-04-19T19:03Z 293.4K followers, [--] engagements "With patients at the core of our research our aim is to bring hope to the fight against #lungcancer #LCSM" [X Link](https://x.com/AstraZeneca/status/987255065864892417) 2018-04-20T09:02Z 293.4K followers, [--] engagements "Our pioneering research harnesses the #science of biomarkers to bring hope to patients with #lungcancer all over the world. #LCSM" [X Link](https://x.com/AstraZeneca/status/987738010811707392) 2018-04-21T17:01Z 293.4K followers, [--] engagements "Our job is to help people be healthy but this goes beyond developing medicines. To mark #EarthDay read more about our commitment to environmental protection: #sustainablehealth http://bit.ly/2K3ehsb http://bit.ly/2K3ehsb" [X Link](https://x.com/AstraZeneca/status/987951909481807872) 2018-04-22T07:11Z 293.4K followers, [--] engagements "Did you know were aiming for 100% renewable power consumption by [----] To mark #EarthDay find out more about our science-based targets for #sustainablehealth: http://bit.ly/2K3ehsb http://bit.ly/2K3ehsb" [X Link](https://x.com/AstraZeneca/status/988013059963740160) 2018-04-22T11:14Z 293.4K followers, [--] engagements "Did you know we are harvesting rainwater at our Macclesfield site Find out more and explore our commitment to #sustainablehealth as we mark this years #EarthDay: http://bit.ly/2K3ehsb http://bit.ly/2K3ehsb" [X Link](https://x.com/AstraZeneca/status/988073956610424832) 2018-04-22T15:16Z 293.4K followers, [--] engagements "We are looking forward to the @CARE_Awards [----] for which we have been shortlisted for the Marquee Award for R&D Excellence Our IMED Biotech Unit has embedded our 5R framework into everything we do from our diverse pipeline to our extraordinary workforce #CAREAwards18" [X Link](https://x.com/AstraZeneca/status/989121751673028608) 2018-04-25T12:39Z 293.4K followers, [--] engagements "Congratulations to @MedImmune's @jsoriamd on receiving @MDAndersonNews' 17th Waun Ki Hong Visiting Professorship https://twitter.com/jsoriamd/status/988850195084562433 https://twitter.com/jsoriamd/status/988850195084562433" [X Link](https://x.com/AstraZeneca/status/989170872828252161) 2018-04-25T15:54Z 293.4K followers, [--] engagements "We are honoured to receive the @CARE_Awards [----] Marquee Award for R&D Excellence Our IMED Biotech Unit has seen a four-fold improvement in pipeline molecules moving from pre-clinical development to Phase III completion #CAREAwards18" [X Link](https://x.com/AstraZeneca/status/989677040990277632) 2018-04-27T01:26Z 293.4K followers, [--] engagements "While #WorldAsthmaDay2018 is an important day for #asthma awareness were committed to following the science in #severeasthma with the aim of improving outcomes for patients every day" [X Link](https://x.com/AstraZeneca/status/991203830078496768) 2018-05-01T06:33Z 293.4K followers, [--] engagements "Asthma is characterised by heterogeneity meaning that patients can present in different ways. Approximately 10% of #asthma patients have #severeasthma which can be difficult to control. By following the science were aiming to transform these patients lives #WorldAsthmaDay2018" [X Link](https://x.com/AstraZeneca/status/991360364649398272) 2018-05-01T16:55Z 293.4K followers, [--] engagements "Proud of 'our' Holly Carter the Royal Society of Chemistry Chemical Sciences Apprentice of the Year winner for [----]. I would encourage anyone thinking about a STEM careers to explore the options of apprenticeships." @RoySocChem https://x.com/CheshireIndy/status/993769976141111296 AstraZeneca chemist wins prestigious royal society of chemistry award https://t.co/cTdptNl8P4 @AstraZeneca @RoySocChem https://t.co/iPVfhnDxDz https://x.com/CheshireIndy/status/993769976141111296 AstraZeneca chemist wins prestigious royal society of chemistry award https://t.co/cTdptNl8P4 @AstraZeneca @RoySocChem" [X Link](https://x.com/AstraZeneca/status/993776327282094080) 2018-05-08T08:55Z 293.4K followers, [--] engagements "Unfortunately apart from surgery in locally advanced cases there is generally no cure for advanced #ovariancancer and 70% of women will relapse after [--] years #gyncsm" [X Link](https://x.com/AstraZeneca/status/994148478212194304) 2018-05-09T09:34Z 293.4K followers, [--] engagements "Ovarian cancer has one of the lowest survival rates of all female cancers but if diagnosed at stage one up to 90% of women with ovarian cancer are likely to survive for five years or more #WorldOvarianCancerDay #WOCD" [X Link](https://x.com/AstraZeneca/status/994179938184937473) 2018-05-09T11:39Z 293.4K followers, [--] engagements "Executive Vice President of our IMED Biotech Unit @MenePangalos is presenting tomorrow at the 2nd Genesis Drug Discovery Conference about innovative #drugdiscovery http://bit.ly/2K5X1lf http://bit.ly/2K5X1lf" [X Link](https://x.com/AstraZeneca/status/994521201367121920) 2018-05-10T10:15Z 293.4K followers, [--] engagements "#Lupus is a commonly misunderstood autoimmune condition. We developed this short video to help explain how it can affect people. #LupusAwarenessMonth" [X Link](https://x.com/AstraZeneca/status/994616378106691587) 2018-05-10T16:33Z 293.4K followers, [--] engagements "We've been mobbing bike seats around Cambridge today to celebrate the great work of @BlueSmileCam. Our [----] Charity of the Year helps children fulfill their true potential and lead happier lives using arts and play-based therapies. #FutureSmiles" [X Link](https://x.com/AstraZeneca/status/996414534779727873) 2018-05-15T15:38Z 293.4K followers, [--] engagements "Were pleased to announce that were embedding @emulatebios Organs-on-Chips technology into our IMED Biotech Unit laboratories to enhance and accelerate our ability to translate science into medicines for patients. http://bit.ly/2IorE4J http://bit.ly/2IorE4J" [X Link](https://x.com/AstraZeneca/status/996727741624942598) 2018-05-16T12:23Z 293.4K followers, [--] engagements "The World #PrecisionMedicine Congress [----] is taking place in London this week. We're proud to have a number of our experts attending including @MenePangalos Joachim Reischl Simon Young Krishna Bulusu Stanley Lazic and Michael Menden. #WPMC18 http://bit.ly/2KuPuMQ http://bit.ly/2KuPuMQ" [X Link](https://x.com/AstraZeneca/status/997026954476904448) 2018-05-17T08:12Z 293.4K followers, [--] engagements "Yesterday @emulatebio announced their strategic collaboration with us which will see us embed their Organs-on-Chips technology into our IMED Biotech Unit laboratories to enhance and accelerate our ability to translate science into medicines for patients http://bit.ly/2IKlShs http://bit.ly/2IKlShs" [X Link](https://x.com/AstraZeneca/status/997039498193063938) 2018-05-17T09:01Z 293.4K followers, [--] engagements "By using @emulatebio Organs-on-Chips technology in our R&D process we aim to improve our ability to predict the effects of our drug candidates in humans and provide better insight into disease biology http://bit.ly/2ImoJO4 http://bit.ly/2ImoJO4" [X Link](https://x.com/AstraZeneca/status/997114803645632512) 2018-05-17T14:01Z 293.4K followers, [--] engagements "We have just published our Q1 [----] financial results: $AZN https://bit.ly/2aSyOlo https://bit.ly/2aSyOlo" [X Link](https://x.com/AstraZeneca/status/997358716893761537) 2018-05-18T06:10Z 293.4K followers, [--] engagements "Our Q1 [----] financial results are now available: $AZN http://bit.ly/2rW82hA http://bit.ly/2rW82hA" [X Link](https://x.com/AstraZeneca/status/997371987952521216) 2018-05-18T07:03Z 293.4K followers, [--] engagements "We use #PrecisionMedicine to identify patients most likely to benefit. Our ambition to analyse [--] million genomes by [----] aims to uncover new disease-related drug targets. #WPMC18" [X Link](https://x.com/AstraZeneca/status/997395794679468033) 2018-05-18T08:37Z 293.4K followers, [--] engagements "We believe theres a distinct connection between maintaining a strong business and making a positive impact to a fairer safer and healthier world. At #WHA71 we look forward to catching up with partners and peers on our mission to achieve #sustainablehealth $AZN" [X Link](https://x.com/AstraZeneca/status/997419794033917952) 2018-05-18T10:13Z 293.4K followers, [--] engagements "Patients with #SevereAsthma continue to struggle with controlling the disease: #ATS2018 http://bit.ly/2k66kXa http://bit.ly/2k66kXa" [X Link](https://x.com/AstraZeneca/status/997437421179494402) 2018-05-18T11:23Z 293.4K followers, [--] engagements "Were excited to welcome experts in immunology & rheumatology to Gaithersburg for the 2nd #IFNSummit. Advancing research into interferon is deepening our understanding of one of the drivers of autoimmune diseases" [X Link](https://x.com/AstraZeneca/status/997456281181999105) 2018-05-18T12:38Z 293.4K followers, [--] engagements "This morning we published our Q1 [----] financial results: $AZN http://bit.ly/2rW82hA http://bit.ly/2rW82hA" [X Link](https://x.com/AstraZeneca/status/997466123959390209) 2018-05-18T13:17Z 293.4K followers, [--] engagements "Despite significant advances in treatment mild asthma continues to be a serious & widespread problem resulting in a substantial burden. Were working to better understand the science behind inflammation of the airways to improve patient outcomes. #ATS2018 http://bit.ly/2LaSgrG http://bit.ly/2LaSgrG" [X Link](https://x.com/AstraZeneca/status/997506874923597824) 2018-05-18T15:59Z 293.4K followers, [--] engagements "The correct answer is true. #SevereAsthma is a heterogenous disease characterised by variable airflow obstruction with cough dyspnoea and wheezing. #ATS2018 http://bit.ly/2LaSgrG http://bit.ly/2LaSgrG" [X Link](https://x.com/AstraZeneca/status/997561730388582400) 2018-05-18T19:37Z 293.4K followers, [--] engagements "Good morning #ATS2018 We will be presenting [--] abstracts. Stay tuned: http://bit.ly/2LaSgrG http://bit.ly/2LaSgrG" [X Link](https://x.com/AstraZeneca/status/997840314390888449) 2018-05-19T14:04Z 293.4K followers, [--] engagements "Find out more about our commitment to our #respiratory work in mild #asthma and #SevereAsthma: http://bit.ly/2LaSgrG http://bit.ly/2LaSgrG" [X Link](https://x.com/AstraZeneca/status/997855918661382144) 2018-05-19T15:06Z 293.4K followers, [--] engagements "Patients suffering from #SevereAsthma can experience multiple comorbidities if they need to rely on long-term OCS. #ATS2018" [X Link](https://x.com/AstraZeneca/status/997874795004944384) 2018-05-19T16:21Z 293.4K followers, [--] engagements "Were committed to evolving our scientific understanding of inflammation with the aim of delivering scientific breakthroughs that transform the lives of people with mild #asthma. #ATS2018 http://bit.ly/2LaSgrG http://bit.ly/2LaSgrG" [X Link](https://x.com/AstraZeneca/status/998189880470523909) 2018-05-20T13:13Z 293.4K followers, [--] engagements "In its first year #HealthyLungAsia has already created [--] partnerships reaching [------] people with education diagnosis and treatment of #COPD or #asthma. Learn more about our #SustainableHealth programme: #WHA71 http://bit.ly/2ImpdQo http://bit.ly/2ImpdQo" [X Link](https://x.com/AstraZeneca/status/998518841348014081) 2018-05-21T11:00Z 293.4K followers, [--] engagements "True or false #Eosinophils are elevated in approximately 15% of #asthma patients. #ATS2018" [X Link](https://x.com/AstraZeneca/status/998534139425910784) 2018-05-21T12:01Z 293.4K followers, [--] engagements "At the core of our #YoungHealthProgramme is a commitment to ensure young people are engaged and have a voice in identifying their health needs as well as planning and delivering solutions. Learn more: #WHA71 http://bit.ly/2vHI8hP http://bit.ly/2vHI8hP" [X Link](https://x.com/AstraZeneca/status/998564097821061120) 2018-05-21T14:00Z 293.4K followers, [--] engagements "Were following the science to investigate #kidney disease and its associated complications as part of our commitment to cardiovascular renal and metabolism patients" [X Link](https://x.com/AstraZeneca/status/998602083254263809) 2018-05-21T16:31Z 293.4K followers, [--] engagements "Senior Director for @AZ_HHA @ashling0410 joined the #WHA71 to talk about #HealthyHeartAfrica and the positive impact of our #sustainablehealth initiatives including conducting [---] million blood pressure screenings in African communities. Learn more: http://bit.ly/2q3XrlA http://bit.ly/2q3XrlA" [X Link](https://x.com/AstraZeneca/status/998609388477677570) 2018-05-21T17:00Z 293.4K followers, [--] engagements "False #Eosinophils are elevated in many more asthma patients - approximately 50%. #EosinophilicAsthma #ATS2018" [X Link](https://x.com/AstraZeneca/status/998629274344013826) 2018-05-21T18:19Z 293.4K followers, [--] engagements "Were exploring how biological pathways characterise conditions like high eosinophil count in #SevereAsthma. #ATS2018" [X Link](https://x.com/AstraZeneca/status/998640346048311298) 2018-05-21T19:03Z 293.4K followers, [--] engagements "Through our #AccessToHealthcare programmes we support you @NCDalliance. Read more about our programmes that support the #EnoughNCDs initiative to #BeatNCDs here: #WHA71 #NCDvoices https://twitter.com/ncdalliance/status/978961705450471424 https://bit.ly/2iq7HC https://twitter.com/ncdalliance/status/978961705450471424 https://bit.ly/2iq7HC" [X Link](https://x.com/AstraZeneca/status/998838378828312576) 2018-05-22T08:10Z 293.4K followers, [--] engagements "Next week its time for our annual #AZExchange networking event at our #Gothenburg Sweden R&D site together with our #BioVentureHub bringing together senior representatives from across the life sciences sector in the Nordic region" [X Link](https://x.com/AstraZeneca/status/998839659617697792) 2018-05-22T08:15Z 293.4K followers, [--] engagements "Merging our #sustainablehealth efforts within #AccessToHealthcare and #EnvironmentalProtection we are excited to announce our collaboration with @CISL_Cambridge to support communities in Kenya by converting waste into clean bio-fuel. #WHA71" [X Link](https://x.com/AstraZeneca/status/998866083716087809) 2018-05-22T10:00Z 293.4K followers, [--] engagements "#TSLP plays an important role in activation of the immune system in response to allergens in #SevereAsthma patients. #ATS2018" [X Link](https://x.com/AstraZeneca/status/998933029354586112) 2018-05-22T14:26Z 293.4K followers, [--] engagements "In many countries healthy food can be more expensive than calorific food that lacks nutrition causing obesity rates to rise. Read the #YoungHealthProgramme study carried out in collaboration with @ImperialCollege addressing this issue: #WHA71 http://bit.ly/2vHI8hP http://bit.ly/2vHI8hP" [X Link](https://x.com/AstraZeneca/status/998971781217071105) 2018-05-22T17:00Z 293.4K followers, [--] engagements "Our Bay Area employees from Acerta Pharma @MedImmune Pearl Therapeutics and TIDE (Technology Innovation & Delivery Excellence) have a new home in South San Francisco http://bit.ly/2rZ43Bw http://bit.ly/2rZ43Bw" [X Link](https://x.com/AstraZeneca/status/999002223240658944) 2018-05-22T19:01Z 293.4K followers, [--] engagements "We are focused on bringing forward new paradigms in #respiratory therapy thats our history and heritage but its also part of our future. #ATS2018" [X Link](https://x.com/AstraZeneca/status/999032680271396864) 2018-05-22T21:02Z 293.4K followers, [--] engagements "Were moving from treatment of #respiratory symptoms to the treatment of the disease drivers for better patient outcomes. #ATS2018 http://bit.ly/2LaSgrG http://bit.ly/2LaSgrG" [X Link](https://x.com/AstraZeneca/status/999057335640182785) 2018-05-22T22:40Z 293.4K followers, [--] engagements "The deadline for the Start-Up Science competition is near The competition is open to early-stage startups that are part of an existing initiative by competition partners @pitchatpalace @opdacam @LucyCavColl @BabrahamUK @CJBS_EC @UCamEnterprise - read more http://bit.ly/2IYzqWI http://bit.ly/2IYzqWI" [X Link](https://x.com/AstraZeneca/status/999275513540632576) 2018-05-23T13:07Z 293.4K followers, [--] engagements "May is #LupusAwarenessMonth and were supporting greater understanding of the science behind #lupus. As a starter: What % of lupus patients are women 60% 70% 90% 80% 60% 70% 90% 80%" [X Link](https://x.com/AstraZeneca/status/999283227012497408) 2018-05-23T13:37Z 293.4K followers, [--] engagements "About 10% of patients have severe asthma a specific type of asthma that may be very difficult to control. Committed to following the science and putting the patient first we are sharing the latest research in severe asthma at #ATS2018" [X Link](https://x.com/AstraZeneca/status/999316804135735296) 2018-05-23T15:51Z 293.4K followers, [--] engagements "In our commitment to follow the science we are continuing to investigate the role of #eosinophils to refine our understanding of underlying drivers in respiratory disease including #severeasthma. #ATS2018" [X Link](https://x.com/AstraZeneca/status/999352291470655489) 2018-05-23T18:12Z 293.4K followers, [--] engagements "Weve had ENOUGH. What about you Support @NCDalliances campaign to #BeatNCDs by taking action #NCDvoices #WHA71 http://bit.ly/2s1FgNk http://bit.ly/2s1FgNk" [X Link](https://x.com/AstraZeneca/status/999373414795132928) 2018-05-23T19:36Z 293.4K followers, [--] engagements "We believe that a better understanding of the persistent and substantial burden of mild #asthma starts with a better understanding of the #science behind inflammation of the airways. #ATS2018 http://bit.ly/2LaSgrG http://bit.ly/2LaSgrG" [X Link](https://x.com/AstraZeneca/status/999413690192486400) 2018-05-23T22:16Z 293.4K followers, [--] engagements "Were excited to present [--] abstracts at #ERAEDTA18 and to demonstrate our commitment to following the science to better understand #cardiorenal care" [X Link](https://x.com/AstraZeneca/status/999598648513019904) 2018-05-24T10:31Z 293.4K followers, [--] engagements "#ATS2018 may be over but our work isnt. Learn about our commitment to improving outcomes for respiratory patients: http://bit.ly/2LaSgrG http://bit.ly/2LaSgrG" [X Link](https://x.com/AstraZeneca/status/999602926636027905) 2018-05-24T10:48Z 293.4K followers, [--] engagements "#Hyperkalaemia is a potentially serious electrolyte condition characterised by elevated levels of potassium in the blood that can disrupt critical bodily processes" [X Link](https://x.com/AstraZeneca/status/999625071986552832) 2018-05-24T12:16Z 293.4K followers, [--] engagements "Weve got a great group of speakers lined up for next weeks #AZExchange Gothenburg event. http://bit.ly/2KJoZDF http://bit.ly/2KJoZDF" [X Link](https://x.com/AstraZeneca/status/999658808178655235) 2018-05-24T14:30Z 293.4K followers, [--] engagements "Were committed to helping shape the future of healthcare in China to deliver better outcomes for patients" [X Link](https://x.com/AstraZeneca/status/999687834578571264) 2018-05-24T16:25Z 293.4K followers, [--] engagements "Did you get our first #LupusAwarenessMonth question right Up to 90% of #lupus patients are women" [X Link](https://x.com/AstraZeneca/status/999718406332014592) 2018-05-24T18:26Z 293.4K followers, [--] engagements "The Cambridge Start-Up Science competition is open to early-stage startups that are part of an existing initiative by competition partners @pitchatpalace @opdacam @LucyCavColl @BabrahamUK @CJBS_EC @UCamEnterprise - The deadline is approaching http://bit.ly/2LhQgxT http://bit.ly/2LhQgxT" [X Link](https://x.com/AstraZeneca/status/999968341233090561) 2018-05-25T11:00Z 293.4K followers, [--] engagements "#CKD patients are at increased risk of developing multiple conditions. An important part of our work is addressing the overlaps between these conditions with the aim of improving outcomes for CVRM patients" [X Link](https://x.com/AstraZeneca/status/999986707901513729) 2018-05-25T12:13Z 293.4K followers, [--] engagements Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
@AstraZeneca AstraZenecaAstraZeneca posts on X about science, we are, $azn, in the the most. They currently have [-------] followers and [---] posts still getting attention that total [--] engagements in the last [--] hours.
Social category influence stocks 99.04% currencies 6.73% countries 2.88% travel destinations 1.92% finance 0.96% exchanges 0.96%
Social topic influence science 18.27%, we are 10.58%, $azn 7.69%, in the 6.73%, future 3.85%, the world 3.85%, to the 3.85%, lives of 2.88%, up to 2.88%, countries 1.92%
Top accounts mentioned or mentioned by @muhayadina38422 @inibica_iis @waynetlc @insoligopoly @apy_fiz @anuragaashish @menepangalos @wethenorth47 @vgrandrounds @diariomedico @yicaichina @cfarmaceutico @asmadual @drlovetruth @baiaforequality @caleblareau @adpdnet @careawards @emulatebio @pitchatpalace
Top assets mentioned AstraZeneca PLC (AZN) Novartis AG (NVS) Gilead Sciences, Inc. (GILD) AbbVie Inc (ABBV)
Top posts by engagements in the last [--] hours
"While the definition of a rare disease varies across countries the number of people affected remains significant. Improving equitable access to healthcare for those living with rare diseases is essential. #RareDisease"
X Link 2025-12-22T13:48Z 293.3K followers, [----] engagements
"#News Exciting newswe are now trading our ordinary shares on the New York Stock Exchange (NYSE) for the first time aligning trading across the NYSE London Stock Exchange (LSE) and Nasdaq Stockholm (STO) under a harmonised global listing structure. #AZN"
X Link 2026-02-02T07:02Z 293.3K followers, [----] engagements
"Newborn screenings and genetic testing play a critical role in accelerating diagnosis and reducing healthcare costs yet access remains limited. Expanding availability of these diagnostic tools can support earlier diagnosis of rare diseases. #RareDisease"
X Link 2026-02-09T13:00Z 293.3K followers, [----] engagements
"#News for #Investors and #Media📈 [----] was another year of strong growth with excellent pipeline delivery across all therapy areas and major regions. Watch our CEO Pascal Soriot share our FY [----] results and learn more: #AZN #FinancialResults https://learn.az/6013h3PrH https://learn.az/6013h3PrH"
X Link 2026-02-10T07:12Z 293.3K followers, [----] engagements
"We're working to reduce the burden of CVD by taking the distinctive approach of jointly addressing cardio-renal-metabolic risks #CVD #ACC18"
X Link 2018-03-12T19:10Z 293.4K followers, [--] engagements
"#ACC18 is over but the conversation for #CVMD patients is not. Lets continue to discuss how and where these diseases intersect to improve patient outcomes"
X Link 2018-03-13T14:16Z 293.4K followers, [--] engagements
"Today we're mentoring entrepreneurs at the #pitchatpalace [---] bootcamp - a great initiative by @TheDukeOfYork to support start-ups develop their business ideas https://x.com/pitchatpalace/status/973473599695867905 [--] Entrepreneurs will Pitch their innovative business idea to an audience of 150+ today and receive business mentoring from their Elevators. https://x.com/pitchatpalace/status/973473599695867905 [--] Entrepreneurs will Pitch their innovative business idea to an audience of 150+ today and receive business mentoring from their Elevators"
X Link 2018-03-13T14:48Z 293.4K followers, [--] engagements
"Today IMED Biotech Unit's @MenePangalos is presenting at the @PistoiaAlliance Conference on the importance of open collaboration in science #Pistoia2018 #collaboration"
X Link 2018-03-14T11:41Z 293.4K followers, [--] engagements
"We are excited to participate in the valuable scientific discussions on advancing #Alzheimers research at @adpdnet #AATADPD"
X Link 2018-03-15T07:11Z 293.4K followers, [--] engagements
"47 million people live with #Alzheimers disease and dementia globally. Increasing patient involvement in research can help improve the future of treatment. #AATADPD http://bit.ly/2FCzj1S http://bit.ly/2FCzj1S"
X Link 2018-03-16T08:05Z 293.4K followers, [--] engagements
"Thank you @ADPDNet for hosting such valuable discussions on the future of #Alzheimers research. #AATADPD"
X Link 2018-03-18T10:21Z 293.4K followers, [--] engagements
"Our CEO Pascal Soriot gave the second annual Kate Pretty lecture at @HomertonCollege part of University of Cambridge. He covered the need for life science clusters to drive innovation and discovery through collaboration and convergence"
X Link 2018-03-20T14:12Z 293.4K followers, [--] engagements
"We are excited to be in Dusseldorf for #Lupus2018 to join the conversation on advancing #lupus research"
X Link 2018-03-20T16:37Z 293.4K followers, [--] engagements
"For those following #Lupus2018 take a moment for a refresher on five important facts about #lupus"
X Link 2018-03-21T09:15Z 293.4K followers, [--] engagements
"#Lupus manifests itself differently in each patient making it difficult to diagnose. These are some but not all of the common symptoms of this autoimmune condition #Lupus2018"
X Link 2018-03-22T08:12Z 293.4K followers, [--] engagements
"By using the treat-to-target approach clinicians could improve treatment outcomes for patients. It involves identifying specific goals in the management of chronic diseases such as #lupus. #Lupus2018"
X Link 2018-03-22T12:33Z 293.4K followers, [--] engagements
"Our renamed Cardiovascular Renal & Metabolism therapy area recognises the importance of #Renal conditions in our distinctive approach to addressing patients cardio-renal-metabolic risks. http://bit.ly/2G3e5qk http://bit.ly/2G3e5qk"
X Link 2018-03-23T11:43Z 293.4K followers, [--] engagements
"With only one new treatment approved in the last [--] years #lupus is an area of significant unmet need for patients. #Lupus2018"
X Link 2018-03-23T12:32Z 293.4K followers, [--] engagements
"Rheumatologist Eric Morand believes that combining treat-to-target with new therapies could revolutionise the treatment of #lupus. #Lupus2018 http://bit.ly/2FQrMN7 http://bit.ly/2FQrMN7"
X Link 2018-03-24T08:22Z 293.4K followers, [--] engagements
"As the @SLEuroSociety #Lupus2018 meeting ends AstraZeneca continues to be committed to improving the treatment of #lupus by pushing the boundaries of research and exploring the drivers of the disease"
X Link 2018-03-24T10:52Z 293.4K followers, [--] engagements
"It is important to learn more about the drivers of #lupus. Thats why were conducting a prospective observational study called SPOCS. #lupus2018"
X Link 2018-03-24T12:02Z 293.4K followers, [--] engagements
"Thank you #Lupus2018 for important conversations on scientific innovation and treatment approaches in #lupus. Our commitment to patients continues"
X Link 2018-03-24T16:12Z 293.4K followers, [--] engagements
"Early diagnosis is an important area of improvement for #OvarianCancer patients. Outcomes are significantly improved if patients are diagnosed at early stages. #SGOMtg #gyncsm"
X Link 2018-03-24T18:04Z 293.4K followers, [--] engagements
"Our IMED Biotech Unit is diversifying their chemical toolbox to explore novel biology and tap into 55% of the biologically-linked genome waiting to be explored. Find out how were working to discover more innovative therapies for patients than ever before: http://bit.ly/2DT2AQp http://bit.ly/2DT2AQp"
X Link 2018-03-28T09:04Z 293.4K followers, [--] engagements
"WSJ.com - Hurdles Multiply for Latest Drugs http://t.co/1uM6gUf http://on.wsj.com/otQNLS http://on.wsj.com/otQNLS"
X Link 2011-08-01T11:39Z 293.4K followers, [--] engagements
"We are proud to be this years no.1 on @ideapharma Pharmaceutical Innovation Index. It is an acknowledgement of the work of our dedicated people and our partners across the world their real passion for science and patient focus. $AZN https://x.com/ideapharma/status/979034387407781891 The [----] Pharmaceutical Innovation Index [--]. @AstraZeneca [--]. @GileadSciences [--]. @JNJNews [--]. @Novartis [--]. @abbvie [--]. @bmsnews [--]. @Merck [--]. @Roche [--]. @pfizer [--]. @biogen 11-32 here: https://t.co/V6Jli1Ayzb https://t.co/N3duZKE9JZ https://x.com/ideapharma/status/979034387407781891 The [----] Pharmaceutical Innovation"
X Link 2018-04-02T17:23Z 293.4K followers, [--] engagements
"We are committed to putting patients first. We aspire to enhance and extend the lives of people with #BloodCancer by following the science to explore new treatment options"
X Link 2018-04-03T08:17Z 293.4K followers, [--] engagements
"Up to 40% of patients diagnosed with hairy cell #leukaemia will ultimately relapse. New therapies are needed for patients with relapsed or refractory disease #BloodCancer"
X Link 2018-04-03T13:19Z 293.4K followers, [--] engagements
"@ryannoyed rude"
X Link 2018-04-05T13:33Z 293.4K followers, [--] engagements
"Positive agreement received for approval of AXANUM (low-dose ASA/esomeprazole) in Europe http://ow.ly/5SSm6"
X Link 2011-08-02T09:20Z 293.4K followers, [--] engagements
"We applaud the steering group supported by @VaccinesEurope for their efforts around raising influenza awareness and EU vaccination rates to reduce the burden of this disease in Europe. Read our blog to find out how you can support these efforts: http://bit.ly/2qbTIAo http://bit.ly/2qbTIAo"
X Link 2018-04-09T11:58Z 293.4K followers, [--] engagements
"Were working hard to understand the reasons behind the increasing burden of #CVD and how to best tackle it as the worlds leading cause of mortality"
X Link 2018-04-09T13:03Z 293.4K followers, [--] engagements
"The impact of #CVD can be immediate and long-lasting. People who develop the disease may be at increased risk of related conditions such as kidney disease and diabetes. Were committed to solving this problem by redefining the way these diseases are understood and treated #CVRM"
X Link 2018-04-09T15:49Z 293.4K followers, [--] engagements
"Our approach to studying the real-world impact of #cardiovascular diseases is designed to bring about better outcomes for patients"
X Link 2018-04-09T16:50Z 293.4K followers, [--] engagements
"Identifying #biomarkers such as #EGFR or ALK can help determine how best to target #lungcancer. Were excited to discuss progress in precision medicine at #ELCC18"
X Link 2018-04-12T13:18Z 293.4K followers, [--] engagements
"@kateandclaudius @kateandclaudius Please find our report here: http://bit.ly/2v8ohNn http://bit.ly/2v8ohNn"
X Link 2018-04-12T22:18Z 293.4K followers, [--] engagements
"Identifying novel risk factors for cardiovascular disease is one way our scientists in the IMED Biotech Unit are defining the 'Right Target in drug discovery. Read more about our 5R framework research approach: http://bit.ly/2DtJu7b http://bit.ly/2DtJu7b"
X Link 2018-04-13T08:46Z 293.4K followers, [--] engagements
"Thank you Geneva and @myESMO for a wonderful #ELCC18. Weve had a great time sharing our #science and learning from our colleagues from around the world. Now onwards to Chicago for #AACR18"
X Link 2018-04-14T11:44Z 293.4K followers, [--] engagements
"Metastases in the central nervous system are difficult to treat due to the blood-brain barrier. Penetrating the barrier remains a significant challenge for researchers looking for ways to improve #lungcancer treatments #AACR18"
X Link 2018-04-15T15:07Z 293.4K followers, [--] engagements
"We strive to put patients first and are working every day to improve the lives of people living with #lungcancer through research #LCSM"
X Link 2018-04-19T13:01Z 293.4K followers, [--] engagements
"Testing for biomarkers at first diagnosis of #lungcancer is important to help doctors and patients better understand their disease #LCSM"
X Link 2018-04-19T16:02Z 293.4K followers, [--] engagements
"Were committed to driving forward research in #lungcancer to fulfil our ambition of improving outcomes for all patients across different stages and types of disease #LCSM"
X Link 2018-04-19T19:03Z 293.4K followers, [--] engagements
"With patients at the core of our research our aim is to bring hope to the fight against #lungcancer #LCSM"
X Link 2018-04-20T09:02Z 293.4K followers, [--] engagements
"Our pioneering research harnesses the #science of biomarkers to bring hope to patients with #lungcancer all over the world. #LCSM"
X Link 2018-04-21T17:01Z 293.4K followers, [--] engagements
"Our job is to help people be healthy but this goes beyond developing medicines. To mark #EarthDay read more about our commitment to environmental protection: #sustainablehealth http://bit.ly/2K3ehsb http://bit.ly/2K3ehsb"
X Link 2018-04-22T07:11Z 293.4K followers, [--] engagements
"Did you know were aiming for 100% renewable power consumption by [----] To mark #EarthDay find out more about our science-based targets for #sustainablehealth: http://bit.ly/2K3ehsb http://bit.ly/2K3ehsb"
X Link 2018-04-22T11:14Z 293.4K followers, [--] engagements
"Did you know we are harvesting rainwater at our Macclesfield site Find out more and explore our commitment to #sustainablehealth as we mark this years #EarthDay: http://bit.ly/2K3ehsb http://bit.ly/2K3ehsb"
X Link 2018-04-22T15:16Z 293.4K followers, [--] engagements
"We are looking forward to the @CARE_Awards [----] for which we have been shortlisted for the Marquee Award for R&D Excellence Our IMED Biotech Unit has embedded our 5R framework into everything we do from our diverse pipeline to our extraordinary workforce #CAREAwards18"
X Link 2018-04-25T12:39Z 293.4K followers, [--] engagements
"Congratulations to @MedImmune's @jsoriamd on receiving @MDAndersonNews' 17th Waun Ki Hong Visiting Professorship https://twitter.com/jsoriamd/status/988850195084562433 https://twitter.com/jsoriamd/status/988850195084562433"
X Link 2018-04-25T15:54Z 293.4K followers, [--] engagements
"We are honoured to receive the @CARE_Awards [----] Marquee Award for R&D Excellence Our IMED Biotech Unit has seen a four-fold improvement in pipeline molecules moving from pre-clinical development to Phase III completion #CAREAwards18"
X Link 2018-04-27T01:26Z 293.4K followers, [--] engagements
"While #WorldAsthmaDay2018 is an important day for #asthma awareness were committed to following the science in #severeasthma with the aim of improving outcomes for patients every day"
X Link 2018-05-01T06:33Z 293.4K followers, [--] engagements
"Asthma is characterised by heterogeneity meaning that patients can present in different ways. Approximately 10% of #asthma patients have #severeasthma which can be difficult to control. By following the science were aiming to transform these patients lives #WorldAsthmaDay2018"
X Link 2018-05-01T16:55Z 293.4K followers, [--] engagements
"Proud of 'our' Holly Carter the Royal Society of Chemistry Chemical Sciences Apprentice of the Year winner for [----]. I would encourage anyone thinking about a STEM careers to explore the options of apprenticeships." @RoySocChem https://x.com/CheshireIndy/status/993769976141111296 AstraZeneca chemist wins prestigious royal society of chemistry award https://t.co/cTdptNl8P4 @AstraZeneca @RoySocChem https://t.co/iPVfhnDxDz https://x.com/CheshireIndy/status/993769976141111296 AstraZeneca chemist wins prestigious royal society of chemistry award https://t.co/cTdptNl8P4 @AstraZeneca @RoySocChem"
X Link 2018-05-08T08:55Z 293.4K followers, [--] engagements
"Unfortunately apart from surgery in locally advanced cases there is generally no cure for advanced #ovariancancer and 70% of women will relapse after [--] years #gyncsm"
X Link 2018-05-09T09:34Z 293.4K followers, [--] engagements
"Ovarian cancer has one of the lowest survival rates of all female cancers but if diagnosed at stage one up to 90% of women with ovarian cancer are likely to survive for five years or more #WorldOvarianCancerDay #WOCD"
X Link 2018-05-09T11:39Z 293.4K followers, [--] engagements
"Executive Vice President of our IMED Biotech Unit @MenePangalos is presenting tomorrow at the 2nd Genesis Drug Discovery Conference about innovative #drugdiscovery http://bit.ly/2K5X1lf http://bit.ly/2K5X1lf"
X Link 2018-05-10T10:15Z 293.4K followers, [--] engagements
"#Lupus is a commonly misunderstood autoimmune condition. We developed this short video to help explain how it can affect people. #LupusAwarenessMonth"
X Link 2018-05-10T16:33Z 293.4K followers, [--] engagements
"We've been mobbing bike seats around Cambridge today to celebrate the great work of @BlueSmileCam. Our [----] Charity of the Year helps children fulfill their true potential and lead happier lives using arts and play-based therapies. #FutureSmiles"
X Link 2018-05-15T15:38Z 293.4K followers, [--] engagements
"Were pleased to announce that were embedding @emulatebios Organs-on-Chips technology into our IMED Biotech Unit laboratories to enhance and accelerate our ability to translate science into medicines for patients. http://bit.ly/2IorE4J http://bit.ly/2IorE4J"
X Link 2018-05-16T12:23Z 293.4K followers, [--] engagements
"The World #PrecisionMedicine Congress [----] is taking place in London this week. We're proud to have a number of our experts attending including @MenePangalos Joachim Reischl Simon Young Krishna Bulusu Stanley Lazic and Michael Menden. #WPMC18 http://bit.ly/2KuPuMQ http://bit.ly/2KuPuMQ"
X Link 2018-05-17T08:12Z 293.4K followers, [--] engagements
"Yesterday @emulatebio announced their strategic collaboration with us which will see us embed their Organs-on-Chips technology into our IMED Biotech Unit laboratories to enhance and accelerate our ability to translate science into medicines for patients http://bit.ly/2IKlShs http://bit.ly/2IKlShs"
X Link 2018-05-17T09:01Z 293.4K followers, [--] engagements
"By using @emulatebio Organs-on-Chips technology in our R&D process we aim to improve our ability to predict the effects of our drug candidates in humans and provide better insight into disease biology http://bit.ly/2ImoJO4 http://bit.ly/2ImoJO4"
X Link 2018-05-17T14:01Z 293.4K followers, [--] engagements
"We have just published our Q1 [----] financial results: $AZN https://bit.ly/2aSyOlo https://bit.ly/2aSyOlo"
X Link 2018-05-18T06:10Z 293.4K followers, [--] engagements
"Our Q1 [----] financial results are now available: $AZN http://bit.ly/2rW82hA http://bit.ly/2rW82hA"
X Link 2018-05-18T07:03Z 293.4K followers, [--] engagements
"We use #PrecisionMedicine to identify patients most likely to benefit. Our ambition to analyse [--] million genomes by [----] aims to uncover new disease-related drug targets. #WPMC18"
X Link 2018-05-18T08:37Z 293.4K followers, [--] engagements
"We believe theres a distinct connection between maintaining a strong business and making a positive impact to a fairer safer and healthier world. At #WHA71 we look forward to catching up with partners and peers on our mission to achieve #sustainablehealth $AZN"
X Link 2018-05-18T10:13Z 293.4K followers, [--] engagements
"Patients with #SevereAsthma continue to struggle with controlling the disease: #ATS2018 http://bit.ly/2k66kXa http://bit.ly/2k66kXa"
X Link 2018-05-18T11:23Z 293.4K followers, [--] engagements
"Were excited to welcome experts in immunology & rheumatology to Gaithersburg for the 2nd #IFNSummit. Advancing research into interferon is deepening our understanding of one of the drivers of autoimmune diseases"
X Link 2018-05-18T12:38Z 293.4K followers, [--] engagements
"This morning we published our Q1 [----] financial results: $AZN http://bit.ly/2rW82hA http://bit.ly/2rW82hA"
X Link 2018-05-18T13:17Z 293.4K followers, [--] engagements
"Despite significant advances in treatment mild asthma continues to be a serious & widespread problem resulting in a substantial burden. Were working to better understand the science behind inflammation of the airways to improve patient outcomes. #ATS2018 http://bit.ly/2LaSgrG http://bit.ly/2LaSgrG"
X Link 2018-05-18T15:59Z 293.4K followers, [--] engagements
"The correct answer is true. #SevereAsthma is a heterogenous disease characterised by variable airflow obstruction with cough dyspnoea and wheezing. #ATS2018 http://bit.ly/2LaSgrG http://bit.ly/2LaSgrG"
X Link 2018-05-18T19:37Z 293.4K followers, [--] engagements
"Good morning #ATS2018 We will be presenting [--] abstracts. Stay tuned: http://bit.ly/2LaSgrG http://bit.ly/2LaSgrG"
X Link 2018-05-19T14:04Z 293.4K followers, [--] engagements
"Find out more about our commitment to our #respiratory work in mild #asthma and #SevereAsthma: http://bit.ly/2LaSgrG http://bit.ly/2LaSgrG"
X Link 2018-05-19T15:06Z 293.4K followers, [--] engagements
"Patients suffering from #SevereAsthma can experience multiple comorbidities if they need to rely on long-term OCS. #ATS2018"
X Link 2018-05-19T16:21Z 293.4K followers, [--] engagements
"Were committed to evolving our scientific understanding of inflammation with the aim of delivering scientific breakthroughs that transform the lives of people with mild #asthma. #ATS2018 http://bit.ly/2LaSgrG http://bit.ly/2LaSgrG"
X Link 2018-05-20T13:13Z 293.4K followers, [--] engagements
"In its first year #HealthyLungAsia has already created [--] partnerships reaching [------] people with education diagnosis and treatment of #COPD or #asthma. Learn more about our #SustainableHealth programme: #WHA71 http://bit.ly/2ImpdQo http://bit.ly/2ImpdQo"
X Link 2018-05-21T11:00Z 293.4K followers, [--] engagements
"True or false #Eosinophils are elevated in approximately 15% of #asthma patients. #ATS2018"
X Link 2018-05-21T12:01Z 293.4K followers, [--] engagements
"At the core of our #YoungHealthProgramme is a commitment to ensure young people are engaged and have a voice in identifying their health needs as well as planning and delivering solutions. Learn more: #WHA71 http://bit.ly/2vHI8hP http://bit.ly/2vHI8hP"
X Link 2018-05-21T14:00Z 293.4K followers, [--] engagements
"Were following the science to investigate #kidney disease and its associated complications as part of our commitment to cardiovascular renal and metabolism patients"
X Link 2018-05-21T16:31Z 293.4K followers, [--] engagements
"Senior Director for @AZ_HHA @ashling0410 joined the #WHA71 to talk about #HealthyHeartAfrica and the positive impact of our #sustainablehealth initiatives including conducting [---] million blood pressure screenings in African communities. Learn more: http://bit.ly/2q3XrlA http://bit.ly/2q3XrlA"
X Link 2018-05-21T17:00Z 293.4K followers, [--] engagements
"False #Eosinophils are elevated in many more asthma patients - approximately 50%. #EosinophilicAsthma #ATS2018"
X Link 2018-05-21T18:19Z 293.4K followers, [--] engagements
"Were exploring how biological pathways characterise conditions like high eosinophil count in #SevereAsthma. #ATS2018"
X Link 2018-05-21T19:03Z 293.4K followers, [--] engagements
"Through our #AccessToHealthcare programmes we support you @NCDalliance. Read more about our programmes that support the #EnoughNCDs initiative to #BeatNCDs here: #WHA71 #NCDvoices https://twitter.com/ncdalliance/status/978961705450471424 https://bit.ly/2iq7HC https://twitter.com/ncdalliance/status/978961705450471424 https://bit.ly/2iq7HC"
X Link 2018-05-22T08:10Z 293.4K followers, [--] engagements
"Next week its time for our annual #AZExchange networking event at our #Gothenburg Sweden R&D site together with our #BioVentureHub bringing together senior representatives from across the life sciences sector in the Nordic region"
X Link 2018-05-22T08:15Z 293.4K followers, [--] engagements
"Merging our #sustainablehealth efforts within #AccessToHealthcare and #EnvironmentalProtection we are excited to announce our collaboration with @CISL_Cambridge to support communities in Kenya by converting waste into clean bio-fuel. #WHA71"
X Link 2018-05-22T10:00Z 293.4K followers, [--] engagements
"#TSLP plays an important role in activation of the immune system in response to allergens in #SevereAsthma patients. #ATS2018"
X Link 2018-05-22T14:26Z 293.4K followers, [--] engagements
"In many countries healthy food can be more expensive than calorific food that lacks nutrition causing obesity rates to rise. Read the #YoungHealthProgramme study carried out in collaboration with @ImperialCollege addressing this issue: #WHA71 http://bit.ly/2vHI8hP http://bit.ly/2vHI8hP"
X Link 2018-05-22T17:00Z 293.4K followers, [--] engagements
"Our Bay Area employees from Acerta Pharma @MedImmune Pearl Therapeutics and TIDE (Technology Innovation & Delivery Excellence) have a new home in South San Francisco http://bit.ly/2rZ43Bw http://bit.ly/2rZ43Bw"
X Link 2018-05-22T19:01Z 293.4K followers, [--] engagements
"We are focused on bringing forward new paradigms in #respiratory therapy thats our history and heritage but its also part of our future. #ATS2018"
X Link 2018-05-22T21:02Z 293.4K followers, [--] engagements
"Were moving from treatment of #respiratory symptoms to the treatment of the disease drivers for better patient outcomes. #ATS2018 http://bit.ly/2LaSgrG http://bit.ly/2LaSgrG"
X Link 2018-05-22T22:40Z 293.4K followers, [--] engagements
"The deadline for the Start-Up Science competition is near The competition is open to early-stage startups that are part of an existing initiative by competition partners @pitchatpalace @opdacam @LucyCavColl @BabrahamUK @CJBS_EC @UCamEnterprise - read more http://bit.ly/2IYzqWI http://bit.ly/2IYzqWI"
X Link 2018-05-23T13:07Z 293.4K followers, [--] engagements
"May is #LupusAwarenessMonth and were supporting greater understanding of the science behind #lupus. As a starter: What % of lupus patients are women 60% 70% 90% 80% 60% 70% 90% 80%"
X Link 2018-05-23T13:37Z 293.4K followers, [--] engagements
"About 10% of patients have severe asthma a specific type of asthma that may be very difficult to control. Committed to following the science and putting the patient first we are sharing the latest research in severe asthma at #ATS2018"
X Link 2018-05-23T15:51Z 293.4K followers, [--] engagements
"In our commitment to follow the science we are continuing to investigate the role of #eosinophils to refine our understanding of underlying drivers in respiratory disease including #severeasthma. #ATS2018"
X Link 2018-05-23T18:12Z 293.4K followers, [--] engagements
"Weve had ENOUGH. What about you Support @NCDalliances campaign to #BeatNCDs by taking action #NCDvoices #WHA71 http://bit.ly/2s1FgNk http://bit.ly/2s1FgNk"
X Link 2018-05-23T19:36Z 293.4K followers, [--] engagements
"We believe that a better understanding of the persistent and substantial burden of mild #asthma starts with a better understanding of the #science behind inflammation of the airways. #ATS2018 http://bit.ly/2LaSgrG http://bit.ly/2LaSgrG"
X Link 2018-05-23T22:16Z 293.4K followers, [--] engagements
"Were excited to present [--] abstracts at #ERAEDTA18 and to demonstrate our commitment to following the science to better understand #cardiorenal care"
X Link 2018-05-24T10:31Z 293.4K followers, [--] engagements
"#ATS2018 may be over but our work isnt. Learn about our commitment to improving outcomes for respiratory patients: http://bit.ly/2LaSgrG http://bit.ly/2LaSgrG"
X Link 2018-05-24T10:48Z 293.4K followers, [--] engagements
"#Hyperkalaemia is a potentially serious electrolyte condition characterised by elevated levels of potassium in the blood that can disrupt critical bodily processes"
X Link 2018-05-24T12:16Z 293.4K followers, [--] engagements
"Weve got a great group of speakers lined up for next weeks #AZExchange Gothenburg event. http://bit.ly/2KJoZDF http://bit.ly/2KJoZDF"
X Link 2018-05-24T14:30Z 293.4K followers, [--] engagements
"Were committed to helping shape the future of healthcare in China to deliver better outcomes for patients"
X Link 2018-05-24T16:25Z 293.4K followers, [--] engagements
"Did you get our first #LupusAwarenessMonth question right Up to 90% of #lupus patients are women"
X Link 2018-05-24T18:26Z 293.4K followers, [--] engagements
"The Cambridge Start-Up Science competition is open to early-stage startups that are part of an existing initiative by competition partners @pitchatpalace @opdacam @LucyCavColl @BabrahamUK @CJBS_EC @UCamEnterprise - The deadline is approaching http://bit.ly/2LhQgxT http://bit.ly/2LhQgxT"
X Link 2018-05-25T11:00Z 293.4K followers, [--] engagements
"#CKD patients are at increased risk of developing multiple conditions. An important part of our work is addressing the overlaps between these conditions with the aim of improving outcomes for CVRM patients"
X Link 2018-05-25T12:13Z 293.4K followers, [--] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
/creator/twitter::AstraZeneca